{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-005585","form_type":"8-K","ticker":"TLRY","cik":"0001731348","company_name":"Tilray Brands, Inc.","filed_at":"2024-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.394308+00:00","generated_at":"2026-05-30T16:45:40.744852+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tilray Q1 revenue $200M (+13%), net loss narrows; beverage alcohol up 132%","bullets":["Net revenue $200M (+13% YoY); gross margin 30% (+500 bps) to $59.7M.","Net loss improved to ($34.7M) from ($55.9M); EPS ($0.04) vs ($0.10) prior year.","Adjusted EBITDA $9.3M vs $10.7M; adjusted EPS loss ($0.01) vs ($0.04).","Beverage alcohol revenue $56M (+132% YoY); cannabis revenue $61.2M; distribution $68.1M.","German medical cannabis flower revenue grew 50% following legalization."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-005585","json":"https://secwatch.observer/filing/0001171843-24-005585.json","markdown":"https://secwatch.observer/filing/0001171843-24-005585.md","text":"https://secwatch.observer/filing/0001171843-24-005585.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1731348/000117184324005585/0001171843-24-005585-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1731348/000117184324005585/f8k_100924.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T16:45:40.744852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}